The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.

Antzeko izenburuak

• Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
  nork: Ulmert, D, et al.
  Argitaratua: (2008)
• Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
  nork: Ulmert, D, et al.
  Argitaratua: (2008)
• Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
  nork: Lilja, H, et al.
  Argitaratua: (2007)
• Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
  nork: Vickers, A, et al.
  Argitaratua: (2010)
• Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
  nork: Vickers, A, et al.
  Argitaratua: (2010)